Risk stratification for invasive aspergillosis in immunocompromised patients

Annals of the New York Academy of Sciences

Volumn 1272, Issue 1, 2012, Pages 23-30

  Herbrecht, Raoul ^a   Bories, Pierre ^a   Moulin, Jean Charles ^a   Ledoux, Marie Pierre ^a   Letscher Bru, Valérie ^b  

^a HÔPITAL DE HAUTEPIERRE   (France)

^b Institut de Parasitologie et de Pathologie Tropicale   (France)

Author keywords

Hematopoietic stem cell transplantation; Invasive aspergillosis; Leukemia; Neutropenia; Risk factors

Indexed keywords

ADALIMUMAB; ALEMTUZUMAB; CORTICOSTEROID; CYCLOSPORIN; INFLIXIMAB; RAPAMYCIN; TACROLIMUS;

ACUTE MYELOBLASTIC LEUKEMIA; ARTICLE; ARTIFICIAL VENTILATION; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER REGRESSION; COMORBIDITY; CORTICOSTEROID THERAPY; CYTOMEGALOVIRUS INFECTION; DIABETES MELLITUS; DRUG EXPOSURE; ENVIRONMENTAL FACTOR; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOCOMPROMISED PATIENT; INCIDENCE; INNATE IMMUNITY; INVASIVE ASPERGILLOSIS; IRON OVERLOAD; KIDNEY FUNCTION; NEUTROPENIA; PROGNOSIS; RESPIRATORY TRACT DISEASE; RISK FACTOR;

EID: 84870915727     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2012.06829.x     Document Type: Article

References (55)

1. Kontoyiannis, D.P., K.A. Marr, B.J. Park, et al 2010. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin. Infect. Dis. 50: 1091-1100.
2. Pagano, L., M. Caira, A. Candoni, et al 2006. The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologica 91: 1068-1075.
3. Lortholary, O., S. Ascioglu, P. Moreau, et al 2000. Invasive aspergillosis as an opportunistic infection in nonallografted patients with multiple myeloma: a European Organization for Research and Treatment of Cancer/ Invasive Fungal Infections Cooperative Group and the Intergroupe Francais du Myelome. Clin. Infect. Dis 30: 41-46.
4. Kim, S.J., J.H. Moon, H. Kim, et al 2012. Non-bacterial infections in Asian patients treated with alemtuzumab: a retrospective study of the Asian Lymphoma Study Group. Leuk. Lymphoma 53: 1515-1524.
5. Pappas, P.G., B.D. Alexander, D.R. Andes, et al 2010. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin. Infect. Dis. 50: 1101-1111.
6. Herbrecht, R., S. Natarajan-Ame, V. Letscher-Bru & M. Canuet 2004. Invasive pulmonary aspergillosis. Semin. Respir. Crit. Care Med. 25: 191-202.
7. Pagano, L., M. Akova, G. Dimopoulos, et al 2011. Risk assessment and prognostic factors for mould-related diseases in immunocompromised patients. J. Antimicrob. Chemother 66(Suppl 1): i5-i14.
8. Nosari, A., P. Oreste, R. Cairoli, et al 2001. Invasive aspergillosis in haematological malignancies: clinical findings and management for intensive chemotherapy completion. Am. J. Hematol. 68: 231-236.
9. Singh, N. & D.L. Paterson 2005. Aspergillus infections in transplant recipients. Clin. Microbiol. Rev. 18: 44-69.
10. Iversen, M., C.M. Burton, S. Vand, et al 2007. Aspergillus infection in lung transplant patients: incidence and prognosis. Eur. J. Clin. Microbiol. Infect. Dis. 26: 879-886.
11. Yan, X., M. Li, M. Jiang, et al 2009. Clinical characteristics of 45 patients with invasive pulmonary aspergillosis: retrospective analysis of 1711 lung cancer cases. Cancer 115: 5018-5025.
12. Garcia-Vidal, C., A. Upton, K.A. Kirby & K.A. Marr 2008. Epidemiology of invasive mold infections in allogeneic stem cell transplant recipients: biological risk factors for infection according to time after transplantation. Clin. Infect. Dis. 47: 1041-1050.
13. Zaoutis, T.E., K. Heydon, J.H. Chu, et al 2006. Epidemiology, outcomes, and costs of invasive aspergillosis in immunocompromised children in the United States, 2000. Pediatrics 117: e711-e716.
14. Robertson, J., O. Elidemir, E.U. Saz, et al 2009. Hypogammaglobulinemia: incidence, risk factors, and outcomes following pediatric lung transplantation. Pediatr. Transplant. 13: 754-759.
15. Murray, C.K., F.L. Loo, D.R. Hospenthal, et al 2008. Incidence of systemic fungal infection and related mortality following severe burns. Burns 34: 1108-1112.
16. Crassard, N., H. Hadden, C. Pondarre, et al 2008. Invasive aspergillosis and allogeneic hematopoietic stem cell transplantation in children: a 15-year experience. Transpl. Infect. Dis. 10: 177-183.
17. Silva, M.F., A.S. Ribeiro, F.J. Fiorot, et al 2012. Invasive aspergillosis: a severe infection in juvenile systemic lupus erythematosus patients. Lupus 21: 1011-1016.
18. Post, M.J., C. Lass-Floerl, G. Gastl & D. Nachbaur 2007. Invasive fungal infections in allogeneic and autologous stem cell transplant recipients: a single-center study of 166 transplanted patients. Transpl. Infect. Dis. 9: 189-195.
19. Kim, H.J., Y.J. Park, W.U. Kim, et al 2009. Invasive fungal infections in patients with systemic lupus erythematosus: experience from affiliated hospitals of Catholic University of Korea. Lupus 18: 661-666.
20. Gao, X., L. Chen, G. Hu & H. Mei 2010. Invasive pulmonary aspergillosis in acute exacerbation of chronic obstructive pulmonary disease and the diagnostic value of combined serological tests. Ann. Saudi. Med. 30: 193-197.
21. Ju, M.K., D.J. Joo, S.J. Kim, et al 2009. Invasive pulmonary aspergillosis after solid organ transplantation: diagnosis and treatment based on 28 years of transplantation experience. Transplant Proc. 41: 375-378.
22. Gil, L., M. Kozlowska-Skrzypczak, A. Mol, et al 2009. Increased risk for invasive aspergillosis in patients with lymphoproliferative diseases after autologous hematopoietic SCT. Bone Marrow Transplant 43: 121-126.
23. Wang, W., C.Y. Zhao, J.Y. Zhou, et al 2011. Invasive pulmonary aspergillosis in patients with HBV-related liver failure. Eur. J. Clin. Microbiol. Infect. Dis. 30: 661-667.
24. Martino, R., J.L. Pinana, R. Parody, et al 2009. Lower respiratory tract respiratory virus infections increase the risk of invasive aspergillosis after a reduced-intensity allogeneic hematopoietic SCT. Bone Marrow Transplant 44: 749-756.
25. Vehreschild, J.J., P.J. Brockelmann, C. Bangard, et al 2012. Pandemic 2009 influenza A(H1N1) virus infection coinciding with invasive pulmonary aspergillosis in neutropenic patients. Epidemiol. Infect. 140: 1848-1852.
26. Ballard, J., L. Edelman, J. Saffle, et al 2008. Positive fungal cultures in burn patients: a multicenter review. J. Burn. Care Res. 29: 213-221.
27. Guinea, J., M. Torres-Narbona, P. Gijon, et al 2010. Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome. Clin. Microbiol. Infect. 16: 870-877.
28. Mihu, C.N., E. King, O. Yossepovitch, et al 2008. Risk factors and attributable mortality of late aspergillosis after T-cell depleted hematopoietic stem cell transplantation. Transpl. Infect. Dis 10: 162-167.
29. Mikulska, M., A.M. Raiola, B. Bruno, et al 2009. Risk factors for invasive aspergillosis and related mortality in recipients of allogeneic SCT from alternative donors: an analysis of 306 patients. Bone Marrow Transplant 44: 361-370.
30. Michallet, M., M. Sobh, S. Morisset, et al 2011. Risk factors for invasive aspergillosis in acute myeloid leukemia patients prophylactically treated with posaconazole. Med. Mycol. 49: 681-687.
31. Bochud, P.Y., J.W. Chien, K.A. Marr, et al 2008. Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation. N. Engl. J. Med. 359: 1766-1777.
32. Kontoyiannis, D.P., G. Chamilos, R.E. Lewis, et al 2007. Increased bone marrow iron stores is an independent risk factor for invasive aspergillosis in patients with high-risk hematologic malignancies and recipients of allogeneic hematopoietic stem cell transplantation. Cancer 110: 1303-1306.
33. Cornely, O.A., J. Maertens, M. Bresnik, et al 2007. Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial). Clin. Infect. Dis 44: 1289-1297.
34. Herbrecht, R., D.W. Denning, T.F. Patterson, et al 2002. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N. Engl. J. Med. 347: 408-415.
35. Herbrecht, R., J. Maertens, L. Baila, et al 2010. Caspofungin first-line therapy for invasive aspergillosis in allogeneic hematopoietic stem cell transplant patients: an European Organisation for Research and Treatment of Cancer study. Bone Marrow Transplant 45: 1227-1233.
36. Viscoli, C., R. Herbrecht, H. Akan, et al 2009. An EORTC Phase II study of caspofungin as first-line therapy of invasive aspergillosis in haematological patients. J. Antimicrob. Chemother. 64: 1274-1281.
37. de Pauw, B., T.J. Walsh, J.P. Donnelly, et al 2008. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin. Infect. Dis. 46: 1813-1821.
38. Nivoix, Y., M. Velten, V. Letscher-Bru, et al 2008. Factors associated with overall and attributable mortality in invasive aspergillosis. Clin. Infect. Dis. 47: 1176-1184.
39. Cordonnier, C., C. Pautas, S. Maury, et al 2009. Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial. Clin. Infect. Dis. 48: 1042-1051.
40. Singh, N. & H.Y. Sun 2008. Iron overload and unique susceptibility of liver transplant recipients to disseminated disease due to opportunistic pathogens. Liver Transplant. 14: 1249-1255.
41. Marr, K.A., R.A. Carter, M. Boeckh, et al 2002. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood 100: 4358-4366.
42. Hellinger, W.C., H. Bonatti, J.D. Yao, et al 2005. Risk stratification and targeted antifungal prophylaxis for prevention of aspergillosis and other invasive mold infections after liver transplantation. Liver Transplant. 11: 656-662.
43. Gordon, S.M. & R.K. Avery 2001. Aspergillosis in lung transplantation: incidence, risk factors, and prophylactic strategies. Transpl. Infect. Dis. 3: 161-167.
44. Cornillet, A., C. Camus, S. Nimubona, et al 2006. Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey. Clin. Infect. Dis. 43: 577-584.
45. Romani, L. 2011. Immunity to fungal infections. Nat. Rev. Immunol. 11: 275-288.
46. Lamoth, F., I. Rubino & P.Y. Bochud 2011. Immunogenetics of invasive aspergillosis. Med. Mycol. 49(Suppl 1): S125-S136.
47. Bochud, P.Y., M. Bochud, A. Telenti & T. Calandra 2007. Innate immunogenetics: a tool for exploring new frontiers of host defence. Lancet Infect. Dis. 7: 531-542.
48. Lambourne, J., D. Agranoff, R. Herbrecht, et al 2009. Association of mannose-binding lectin deficiency with acute invasive aspergillosis in immunocompromised patients. Clin. Infect. Dis. 49: 1486-1491.
49. Sainz, J., C.B. Lupianez, J. Segura-Catena, et al 2012. Dectin-1 and DC-SIGN polymorphisms associated with invasive pulmonary Aspergillosis infection. PLoS One 7: e32273.
50. Zaas, A.K., G. Liao, J.W. Chien, et al 2008. Plasminogen alleles influence susceptibility to invasive aspergillosis. PLoS Genet. 4: e1000101.
51. Panackal, A.A., H. Li, D.P. Kontoyiannis, et al 2010. Geoclimatic influences on invasive aspergillosis after hematopoietic stem cell transplantation. Clin. Infect. Dis. 50: 1588-1597.
52. Szyper-Kravitz, M., R. Lang, Y. Manor & M. Lahav 2001. Early invasive pulmonary aspergillosis in a leukemia patient linked to aspergillus contaminated marijuana smoking. Leuk. Lymphoma 42: 1433-1437.
53. Verweij, P.E., J.J. Kerremans, A. Voss & J.F. Meis 2000. Fungal contamination of tobacco and marijuana. JAMA 284: 2875.
54. Ribaud, P., C. Chastang, J.P. Latge, et al 1999. Survival and prognostic factors of invasive aspergillosis after allogeneic bone marrow transplantation. Clin. Infect. Dis. 28: 322-330.
55. Upton, A., K.A. Kirby, P. Carpenter, et al 2007. Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality. Clin. Infect. Dis. 44: 531-540.